Jane Street Group, LLC Adamis Pharmaceuticals Corp Transaction History

Jane Street Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.14 - $0.22 $13,555 - $21,301	96,824 New	96,824 $16,000
Q2 2022 Aug 16, 2022	BUY	$0.34 - $0.57 $5,923 - $9,930	17,422 New	17,422 $9,000
Q1 2022 May 17, 2022	SELL	$0.55 - $0.73 $22,943 - $30,452	-41,716 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.57 - $1.23 $17,421 - $37,593	30,564 Added 274.07%	41,716 $25,000
Q3 2021 Nov 16, 2021	SELL	$0.92 - $1.18 $3,766 - $4,830	-4,094 Reduced 26.85%	11,152 $11,000
Q1 2021 May 18, 2021	BUY	$0.54 - $1.79 $8,232 - $27,290	15,246 New	15,246 $15,000
Q4 2020 Feb 17, 2021	SELL	$0.4 - $1.01 $8,111 - $20,481	-20,279 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$0.52 - $1.45 $8,736 - $24,361	-16,801 Reduced 45.31%	20,279 $16,000
Q2 2020 Aug 17, 2020	BUY	$0.33 - $0.66 $12,236 - $24,472	37,080 New	37,080 $20,000
Q1 2020 May 15, 2020	SELL	$0.33 - $0.89 $5,606 - $15,120	-16,989 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.51 - $1.26 $8,664 - $21,406	16,989 New	16,989 $12,000
Q1 2019 May 16, 2019	SELL	$2.02 - $3.22 $27,754 - $44,242	-13,740 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$2.1 - $3.21 $28,854 - $44,105	13,740 New	13,740 $31,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.